Modification of the association between age and mortality in heart failure by frailty status
Heart failure patients identified as frail need treatment checks, since doctors prescribe fewer medications to them regardless of age—a fixable gap.
In a nationwide Danish registry of 79,193 HF patients, frailty status profoundly shifted the mortality-age relationship, with high-frailty 47-year-olds having comparable 2-year mortality to low-frailty 80-year-olds (~22%). GDMT use was consistently lower in frail patients at every age, highlighting a major treatment gap that supports frailty-informed management protocols.
What the study was
- Study design
- Nationwide registry cohort study
- Population
- New-onset HF patients in Denmark 2013-2022, stratified by age (<65, 65-79, ≥80) and frailty (Hospital Frailty Risk Score)
- Sample size
- 79193
- Category
- Public Health
- Maturity
- Validated
- Journal
- European Journal of Heart Failure
Why it surfaced
Large nationwide registry (N=79,193) demonstrating that frailty, not chronological age, is the primary driver of HF mortality risk, with quantified mortality equivalence across 33-year age gap. GDMT underuse in frail patients identified as actionable gap. Published in European Journal of Heart Failure, high clinical translation potential.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.